Department of Pharmacology and Toxicology; Program in Neuroscience, Jacobs School of Medicine and Biomedical Sciences, The State University of New York at Buffalo, Buffalo, NY, USA.
National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA.
Mol Psychiatry. 2022 Jan;27(1):296-306. doi: 10.1038/s41380-021-01186-y. Epub 2021 Jun 15.
Neuropsychiatric diseases are manifested by maladaptive behavioral plasticity. Despite the greater understanding of the neuroplasticity underlying behavioral adaptations, pinpointing precise cellular mediators has remained elusive. This has stymied the development of pharmacological interventions to combat these disorders both at the level of progression and relapse. With increased knowledge on the putative role of the transforming growth factor (TGF- β) family of proteins in mediating diverse neuroadaptations, the influence of TGF-β signaling in regulating maladaptive cellular and behavioral plasticity underlying neuropsychiatric disorders is being increasingly elucidated. The current review is focused on what is currently known about the TGF-β signaling in the central nervous system in mediating cellular and behavioral plasticity related to neuropsychiatric manifestations.
神经精神疾病表现为适应不良的行为可塑性。尽管人们对行为适应所依赖的神经可塑性有了更深入的了解,但确定精确的细胞介导物仍然难以捉摸。这阻碍了针对这些疾病进展和复发的药理学干预措施的发展。随着人们对转化生长因子 (TGF-β) 蛋白家族在介导多种神经适应性中的假定作用的认识不断增加,TGF-β 信号在调节神经精神疾病中与适应不良的细胞和行为可塑性的影响也越来越明显。目前的综述重点介绍了目前已知的 TGF-β 信号在中枢神经系统中调节与神经精神表现相关的细胞和行为可塑性的作用。